NSC 107512 is a potent inhibitor of cyclin-dependent kinase 9 ( CDK9 ). NSC 107512 is a class of sangivamycin-like molecules (SLM). NSC 107512 inhibits growth and induces apoptosis of multiple myeloma tumorsForm:SolidIC50&: Target:CDK9.
NSC 107512 is a potent inhibitor of cyclin-dependent kinase 9 ( CDK9 ). NSC 107512 is a class of sangivamycin-like molecules (SLM). NSC 107512 inhibits growth and induces apoptosis of multiple myeloma tumorsForm:SolidIC50&: Target:CDK9.